Table 2 Comorbidities frequency stratified by group
Comorbidity | All patients (N = 2041) | |||
|---|---|---|---|---|
Group 1 | Group 2 | Group 3 | p-value | |
Skull and face | Vertebral column | Sacrum/ coccyx | ||
n = 1214 (69.1%) | n = 297 (16.9%) | n = 246 (14%) | ||
Tobacco use, n (%) | 219 (18%) | 34 (11%) | 40 (16%) | 0.0235 |
Osteoporosis, n (%) | 25 (2%) | 13 (4%) | 1 (0.4%) | 0.006 |
Hypertension, n (%) | 528 (43.4%) | 104 (35%) | 77 (31%) | 0.0002 |
CHF, n (%) | 45 (3.7%) | 5 (1.68%) | 9 (3.6%) | 0.2134 |
COPD, n (%) | 180 (14.8%) | 35 (11.78%) | 22 (9%) | 0.0308 |
MI, n (%) | 120 (9.8%) | 25 (8.42%) | 24 (9.7%) | 0.7419 |
Diabetes, n (%) | 169 (13.9%) | 36 (12.12%) | 25 (10%) | 0.2423 |
Obesity, n (%) | 66 (5.4%) | 20 (6.73%) | 21 (8.5%) | 0.1575 |
At least one of the above, n (%) | 807 (66.4%) | 172 (57.9%) | 133 (54%) | 0.0001 |